Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250,867 | 278,598 | 326,441 | 466,544 | 439,195 |
| Receivables | 20,316 | 25,182 | 72,971 | 30,218 | N/A |
| Inventories | 18,387 | 16,177 | 12,073 | 11,122 | N/A |
| Other current assets | 9,450 | 5,990 | 23,495 | 17,298 | 11,255 |
| TOTAL | $307,390 | $336,291 | $434,980 | $525,182 | $450,450 |
| Non-Current Assets | |||||
| PPE Net | 5,075 | 5,622 | 3,355 | 4,066 | 1,629 |
| Investments And Advances | 0 | 1,647 | 7,613 | 41,236 | 47,908 |
| Intangibles | 0 | 0 | 0 | 13,582 | 10,179 |
| Other Non-Current Assets | 9,515 | 11,222 | 44,911 | 33,906 | 3,526 |
| TOTAL | $14,590 | $18,491 | $55,879 | $92,790 | $63,242 |
| Total Assets | $321,980 | $354,782 | $490,859 | $617,972 | $513,692 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 6,575 | 3,631 |
| Accounts payable and accrued liabilities | 18,029 | 15,569 | 12,351 | 12,080 | 5,279 |
| Accrued Expenses | 62,440 | 52,101 | 68,491 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 50,497 | 30,375 |
| TOTAL | $80,469 | $67,670 | $81,939 | $73,935 | $40,436 |
| Non-Current Liabilities | |||||
| Long Term Debt | 113,632 | 112,730 | 109,714 | N/A | N/A |
| Other Non-Current Liabilities | 330,521 | 322,631 | 219,755 | 377,949 | 137,751 |
| TOTAL | $444,153 | $435,361 | $329,469 | $377,949 | $137,751 |
| Total Liabilities | $524,622 | $503,031 | $411,408 | $451,884 | $178,187 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,084 | N/A | N/A | N/A | N/A |
| Common Shares | 8,425 | 7,312 | 7,312 | 6,445 | 6,314 |
| Retained earnings | -1,493,318 | -1,335,472 | -1,095,419 | -924,885 | -694,859 |
| Other shareholders' equity | -1,641 | 366 | 2,144 | 102,701 | 42,994 |
| TOTAL | $-202,642 | $-148,249 | $79,451 | $166,088 | $335,505 |
| Total Liabilities And Equity | $321,980 | $354,782 | $490,859 | $617,972 | $513,692 |